Axiom Financial Strategies’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,237
Closed -$205K 51
2025
Q1
$205K Buy
+1,237
New +$194K 0.12% 46
2023
Q1
Sell
-1,175
Closed -$208K 38
2022
Q4
$208K Sell
1,175
-2,545
-68% -$439K 0.13% 36
2022
Q3
$608K Buy
3,720
+7
+0.2% +$1.19K 0.32% 40
2022
Q2
$659K Hold
3,713
0.35% 39
2022
Q1
$668K Sell
3,713
-19
-0.5% -$3.23K 0.34% 40
2021
Q4
$638K Buy
3,732
+3
+0.1% +$491 0.29% 38
2021
Q3
$602K Buy
3,729
+18
+0.5% +$3.07K 0.28% 40
2021
Q2
$611K Sell
3,711
-65
-2% -$10.8K 0.28% 37
2021
Q1
$621K Buy
3,776
+109
+3% +$17.6K 0.31% 37
2020
Q4
$546K Hold
3,667
0.33% 37
2020
Q3
$546K Buy
3,667
+283
+8% +$41.9K 0.33% 37
2020
Q2
$476K Sell
3,384
-286
-8% -$41.7K 0.31% 37
2020
Q1
$481K Buy
+3,670
New +$521K 0.39% 36

Other funds holding JNJ

Axiom Financial Strategies's JNJ Position: Q2 2025 in Review

Axiom Financial Strategies sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 1,237 shares — an estimated $205K sold.

Axiom Financial Strategies first reported a position in JNJ in Q1 2020 and held it in 13 quarters. The position peaked at $668K in Q1 2022. 4,083 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Axiom Financial Strategies reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
  • Axiom Financial Strategies sold 1,237 Johnson & Johnson shares in Q2 2025, an estimated $205K.
  • Axiom Financial Strategies first reported a position in Johnson & Johnson in Q1 2020 and held it in 13 quarters.
  • Axiom Financial Strategies's Johnson & Johnson position peaked at $668K in Q1 2022.
  • 4,083 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Axiom Financial Strategies's 13F filing for Q2 2025, filed 30 Jul 2025.